In this episode, we explore the booming Tyrosine Kinase Inhibitors (TKIs) market, projected to hit USD 69.24 billion by 2025, growing at a CAGR of 8.7% through 2033. North America leads the charge with over 37% market share, followed by Europe and the rapidly expanding APAC region. We also dive into the fastest-growing segment—lung cancer treatment—and discuss why TKIs are becoming critical in oncology. Tune in to get a region-wise breakdown and insights on what’s driving this high-impact pharmaceutical market.

Visit:https://www.cognitivemarketresearch.com/tyrosine-kinase-inhibitor-market-report